JP2005289938A5 - - Google Patents

Download PDF

Info

Publication number
JP2005289938A5
JP2005289938A5 JP2004110487A JP2004110487A JP2005289938A5 JP 2005289938 A5 JP2005289938 A5 JP 2005289938A5 JP 2004110487 A JP2004110487 A JP 2004110487A JP 2004110487 A JP2004110487 A JP 2004110487A JP 2005289938 A5 JP2005289938 A5 JP 2005289938A5
Authority
JP
Japan
Prior art keywords
parts
weight
mass
mass parts
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004110487A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005289938A (ja
JP4836044B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2004110487A priority Critical patent/JP4836044B2/ja
Priority claimed from JP2004110487A external-priority patent/JP4836044B2/ja
Publication of JP2005289938A publication Critical patent/JP2005289938A/ja
Publication of JP2005289938A5 publication Critical patent/JP2005289938A5/ja
Application granted granted Critical
Publication of JP4836044B2 publication Critical patent/JP4836044B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004110487A 2004-04-02 2004-04-02 経口アミノ酸ニキビ治療剤 Expired - Fee Related JP4836044B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004110487A JP4836044B2 (ja) 2004-04-02 2004-04-02 経口アミノ酸ニキビ治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004110487A JP4836044B2 (ja) 2004-04-02 2004-04-02 経口アミノ酸ニキビ治療剤

Publications (3)

Publication Number Publication Date
JP2005289938A JP2005289938A (ja) 2005-10-20
JP2005289938A5 true JP2005289938A5 (cg-RX-API-DMAC7.html) 2007-05-31
JP4836044B2 JP4836044B2 (ja) 2011-12-14

Family

ID=35323287

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004110487A Expired - Fee Related JP4836044B2 (ja) 2004-04-02 2004-04-02 経口アミノ酸ニキビ治療剤

Country Status (1)

Country Link
JP (1) JP4836044B2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069462A (zh) 2016-02-23 2018-12-21 癌症研究科技有限公司 缺乏至少两种非必需氨基酸的膳食产品
JP2023530235A (ja) 2020-06-03 2023-07-14 フェス・セラピューティクス,インコーポレーテッド 個別化された処置方法のための製剤
WO2021247923A1 (en) 2020-06-04 2021-12-09 Faeth Therapeutics, Inc. Personalized methods of treating cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616617A (en) * 1995-11-27 1997-04-01 Van Moerkerken; Arthur Face pimples prevention method and compositions
AU737199B2 (en) * 1997-09-17 2001-08-09 Strategic Science & Technologies, Llc A delivery of arginine to cause beneficial effects
JPH11269034A (ja) * 1998-03-20 1999-10-05 Shiseido Co Ltd ニキビ改善用皮膚外用剤
FR2778562B1 (fr) * 1998-05-14 2000-08-04 Sephra Composition pharmaceutique, hygienique et/ou cosmetique contenant de l'eau de mer et de l'arginine
JP2001224334A (ja) * 2000-02-16 2001-08-21 Ajinomoto Co Inc アミノ酸含有美容食品
JP3827923B2 (ja) * 2000-06-20 2006-09-27 味の素株式会社 造血および栄養状態改善用アミノ酸組成物
US7338675B2 (en) * 2002-05-10 2008-03-04 Tsi Health Sciences, Inc. Fenugreek seed bio-active compositions and methods for extracting same

Similar Documents

Publication Publication Date Title
WO2008081582A1 (ja) 容器詰飲料
ES2111384T3 (es) Composicion dietetica para adolescentes.
JP2009517473A5 (cg-RX-API-DMAC7.html)
EP1582208A3 (en) An amino acid compositions for promoting collagen synthesis
JP2011523626A5 (cg-RX-API-DMAC7.html)
WO2005103228A3 (en) L-amino acid-producing bacterium and a method for producing l-amino acid
JP2010513259A5 (cg-RX-API-DMAC7.html)
ATE541568T1 (de) Infusionsflüssigkeit zur behandlung der anämie bei dialysepatienten
JPS61247354A (ja) 栄養素組成物
JP2005289938A5 (cg-RX-API-DMAC7.html)
ATE504580T1 (de) Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
ATE360424T1 (de) 2,3,4,5-tetrahydrobenzo[fö]1,4öoxazepin-5- carbonsäureamid derivate als gamma-secretase inhibitoren zur behandlung von alzheimer
DE602004026514D1 (de) Orale Zusammensetzung aus Naturstoffen zum Erhalt der richtigen Hautfeuchtigkeit
JP2006516141A5 (cg-RX-API-DMAC7.html)
JP2004534073A5 (cg-RX-API-DMAC7.html)
KR970701727A (ko) 신규한 아미노산 유도체, 이들의 제조방법 및 이들 화합물을 포함하는 약제학적 조성물(Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds)
JP2019515881A5 (cg-RX-API-DMAC7.html)
JP2003286168A5 (cg-RX-API-DMAC7.html)
RU2005101110A (ru) Способ получения l-аминокислот с использованием бактерии семейства enterobacteriaceae, в которой разрушен путь биосинтеза гликогена
JP6423717B2 (ja) 非糖質性エネルギー産生増強剤
JP2009515953A5 (cg-RX-API-DMAC7.html)
CA2586239A1 (en) Methods for regulating weight and size of animals with glycine
RU2022133861A (ru) Раствор для лечения вульвовагинальных и внутриматочных заболеваний
TH78673A (th) องค์ประกอบของผลิตภัณฑ์ยาที่มีกรดอะมิโนที่สิ่งมีชีวิตสังเคราะห์ได้เองและวิธีใช้
RU2021115474A (ru) Композиция для лечебного питания